Annual Operating Expenses
$447.26 M
+$79.42 M+21.59%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual total operating expenses is $447.26 million, with the most recent change of +$79.42 million (+21.59%) on December 31, 2023.
- During the last 3 years, CERE annual operating expenses has risen by +$298.15 million (+199.94%).
Performance
CERE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$142.66 M
+$3.09 M+2.22%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly total operating expenses is $142.66 million, with the most recent change of +$3.09 million (+2.22%) on March 31, 2024.
- Over the past year, CERE quarterly operating expenses has increased by +$31.35 million (+28.16%).
Performance
CERE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CERE Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.6% | +28.2% |
| 3 y3 years | +199.9% | +96.7% |
| 5 y5 years | +435.9% | +96.7% |
CERE Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -50.8% | at high | -54.8% |
| 5 y | 5-year | at high | -81.3% | at high | -75.9% |
| alltime | all time | at high | -81.3% | at high | -75.9% |
Cerevel Therapeutics Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $142.66 M(+2.2%) |
| Dec 2023 | $447.26 M(+21.6%) | $139.56 M(+25.4%) |
| Sep 2023 | - | $111.31 M(+14.9%) |
| Jun 2023 | - | $96.84 M(-2.7%) |
| Mar 2023 | - | $99.55 M(-7.2%) |
| Dec 2022 | $367.85 M(+67.1%) | $107.25 M(+12.8%) |
| Sep 2022 | - | $95.06 M(+2.2%) |
| Jun 2022 | - | $93.01 M(+28.2%) |
| Mar 2022 | - | $72.53 M(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $220.10 M(+47.6%) | $64.49 M(+18.3%) |
| Sep 2021 | - | $54.53 M(+8.0%) |
| Jun 2021 | - | $50.51 M(-0.1%) |
| Mar 2021 | - | $50.57 M(+20.7%) |
| Dec 2020 | $149.12 M(+78.7%) | $41.90 M(+21.9%) |
| Sep 2020 | - | $34.36 M(-2.3%) |
| Jun 2020 | - | $35.16 M(-6.8%) |
| Mar 2020 | - | $37.70 M |
| Dec 2019 | $83.46 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual operating expenses year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly operating expenses year-on-year change?
What is Cerevel Therapeutics Holdings annual total operating expenses?
The current annual operating expenses of CERE is $447.26 M
What is the all time high annual operating expenses for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual total operating expenses is $447.26 M
What is Cerevel Therapeutics Holdings annual operating expenses year-on-year change?
Over the past year, CERE annual total operating expenses has changed by +$79.42 M (+21.59%)
What is Cerevel Therapeutics Holdings quarterly total operating expenses?
The current quarterly operating expenses of CERE is $142.66 M
What is the all time high quarterly operating expenses for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly total operating expenses is $142.66 M
What is Cerevel Therapeutics Holdings quarterly operating expenses year-on-year change?
Over the past year, CERE quarterly total operating expenses has changed by +$31.35 M (+28.16%)